J 2021

European survey on national harmonization in clinical research

MAGNIN, Anette, Valentina Cabral IVERSEN, Gonzalo CALVO, Beata ČEČETKOVÁ, Ola DALE et. al.

Basic information

Original name

European survey on national harmonization in clinical research

Authors

MAGNIN, Anette (756 Switzerland), Valentina Cabral IVERSEN (578 Norway), Gonzalo CALVO (724 Spain), Beata ČEČETKOVÁ (703 Slovakia), Ola DALE, Regina DEMLOVÁ (203 Czech Republic, guarantor, belonging to the institution), György BLASKÓ (348 Hungary), Fionnuala KEANE (372 Ireland), Gabor L. KOVACS (348 Hungary), Claire LEVY-MARCHAL (250 France), Emilia C. MONTEIRO (620 Portugal), Lucia PALMISANO, Daniel PELLA (703 Slovakia), Antonio PORTOLÉS (724 Spain), Olivier RASCOL (250 France), Caecilia SCHMID, Fabian TAY, Heiko VON DER LEYEN and Christian OHMANN

Edition

Learning Health Systems, Hoboken, Wiley, 2021, 2379-6146

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30230 Other clinical medicine subjects

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14110/21:00121081

Organization unit

Faculty of Medicine

UT WoS

000641767400005

Keywords in English

Clinical research; Clinical study; Clinical trial; Survey; Training; GCP-training; ECRIN; Career options; Training requirements; Clinical study personnel

Tags

International impact, Reviewed
Změněno: 8/2/2022 09:03, Mgr. Tereza Miškechová

Abstract

V originále

Background: Clinical trials remain key to the development of evidence-based medical practice. However, they are becoming increasingly complex, mainly in a multinational setting. To address these challenges, the European Union (EU) adopted the Clinical Trial Regulation EU No. 536/2014 (CTR). Once in force, the CTR will lead to more consistent rules and simplification of procedures for conducting clinical trials throughout the EU. Existing harmonization initiatives and “research infrastructures” for clinical trials may facilitate this process. This publication offers a snapshot of the current level of harmonization activities in academic clinical research in Europe. Methods: A survey was performed among the member and observer countries of the European Clinical Research Infrastructure Network (ECRIN), using a standardized questionnaire. Three rounds of data collection were performed to maximize completeness and comparability of the received answers. The survey aimed to describe the harmonization of academic clinical research processes at national level, to facilitate the exchange of expertise and experience among countries, and to identify new fields of action. Results: Most scientific partners already have in place various working groups and harmonization activities at national level. Furthermore, they are involved in and open to sharing their know-how and documents. Since harmonization was mainly a bottom-up approach up until now, the extent and topics dealt with are diverse and there is only little cross-networking and cross-country exchange so far. Conclusions: Currently, the ECRIN member countries offer a very solid base and collaborative spirit for further aligning processes and exchanging best practices for clinical research in Europe. They can support a smooth implementation of the EU CTR and may act as single contact with consolidated expertise in a country.

Links

90128, large research infrastructures
Name: CZECRIN III